Understanding Free Phenytoin Levels
Free phenytoin levels measure the unbound, pharmacologically active fraction of phenytoin in the blood, which is the only portion that exerts therapeutic effects and causes toxicity—this measurement is critical because total phenytoin levels can be misleading in many clinical situations.
What Are Free Phenytoin Levels?
Phenytoin is highly protein-bound (>90% bound to albumin) 1. Only the unbound or "free" fraction crosses cell membranes, enters the brain, and produces anticonvulsant effects. The free fraction normally represents approximately 8-12% of the total phenytoin concentration 2.
- Total phenytoin: Measures both bound and unbound drug
- Free phenytoin: Measures only the pharmacologically active, unbound drug
- Therapeutic range for free phenytoin: 1-2 mcg/mL (compared to 10-20 mcg/mL for total phenytoin) 1
Clinical Significance: When Total Levels Mislead
Total phenytoin concentrations are unreliable in approximately 30% of patients 2, particularly in critically ill populations where discordance between free and total levels can reach 53% 2. This creates dangerous situations where patients may have:
- Toxic free levels despite therapeutic total levels (10% of critically ill children) 3
- Subtherapeutic free levels despite adequate total levels
High-Risk Clinical Situations Requiring Free Phenytoin Measurement:
Hypoalbuminemia (albumin <2.5 g/dL):
- Free fraction increases dramatically, reaching as high as 0.22 (22%) compared to normal 0.10-0.12 3
- 50% of patients with altered albumin have free fractions outside the expected 8-12% range 2
- Common in critically ill patients, malnutrition, nephrotic syndrome, cirrhosis, burns
Renal failure/uremia:
- Uremic toxins compete for albumin binding sites
- Increases free fraction even with normal albumin levels 2
Drug interactions with highly protein-bound medications:
- Valproic acid: Significantly increases free phenytoin fraction (p<0.001) 3
- Cefazolin: Increases free fraction (p<0.001) 3
- Other highly protein-bound drugs can displace phenytoin
Pregnancy:
- Altered protein binding and increased volume of distribution 2
Critical illness:
- Free/total ratios in critically ill children range from 0.06-0.42 (mean 0.13 ± 0.07) 3
- Much greater variability than in adults
The Problem with Calculated Free Phenytoin
The Sheiner-Tozer equation is commonly used to estimate free phenytoin from total levels and albumin:
Adjusted phenytoin = Total phenytoin / [(0.2 × albumin) + 0.1]
However, this equation is unreliable in critically ill patients:
- Underestimates free phenytoin more frequently than overestimates 4
- Mean difference between calculated and measured free phenytoin: -0.31 ± 0.5 mcg/mL (95% CI: -1.3 to 0.7) 3
- Particularly unreliable in critically ill children where it should not be used 3
- Shows wide variability with clinically significant negative bias 5
- The relationship between free phenytoin and albumin is nonlinear, limiting equation accuracy 3
While the Sheiner-Tozer equation may have utility in stable adult patients with mild hypoalbuminemia (albumin 25-35 g/dL) 6, direct measurement of free phenytoin is superior 4, 2.
Clinical Recommendations
Measure free phenytoin directly (not calculated) in:
- All critically ill patients, especially children 3
- Hypoalbuminemia (albumin <3.5 g/dL, particularly <2.5 g/dL)
- Renal failure or uremia
- Patients on valproic acid, cefazolin, or other highly protein-bound drugs
- Pregnancy
- When total phenytoin levels don't correlate with clinical response
- When dose adjustments based on total levels lead to unexpected toxicity or lack of efficacy
For routine monitoring in stable patients:
- Total phenytoin may suffice if albumin is normal and no interacting drugs present
- However, free phenytoin provides more reliable therapeutic guidance 2
Important Caveats
- Free phenytoin measurement is more costly and time-consuming than total phenytoin 4
- Samples must be handled properly (ultra-performance liquid chromatography tandem mass spectrometry) 5
- Timing matters: Trough levels (just before next dose) are most useful for monitoring 1
- Peak levels occur 4-12 hours after oral administration 1
- Steady-state requires 7-10 days (5-7 half-lives) after dose changes 1
The risk of using calculated values or total phenytoin alone in high-risk patients is phenytoin toxicity (ataxia, nystagmus, altered consciousness, cardiac effects) or treatment failure from subtherapeutic dosing 7.